RSLS

ReShape Lifesciences, Inc.

0.18 USD
+0.00 (+0.45%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ReShape Lifesciences, Inc. stock is up 4.12% since 30 days ago. The next earnings date is May 31, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 7 May’s closed higher than April.

About ReShape Lifesciences, Inc.

ReShape Lifesciences Inc. provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. Its product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes.